查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1504997

非侵入性產前檢查市場，佔有率，規模，趨勢，產業分析報告:各妊娠期間，各組成類別，各方法，各用途，各最終用途，各地區，各市場區隔預測，2024年～2032年

Non-Invasive Prenatal Testing Market Share, Size, Trends, Industry Analysis Report, By Gestation Period; By Component; By Method; By Application; By End-Use; By Regions; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，到 2032 年，全球無創產前檢測 (NIPT) 市場規模預計將達到 101 億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

由於遺傳疾病發生率的增加、早期胎兒檢測意識的提高以及孕產婦年齡的增加，預計在預測期內，非侵入性產前檢測的市場需求將會增加。醫療基礎設施市場的顯著成長、技術進步和有利的監管是預計在預測期內提供成長機會的一些因素。

孕齡段分為0-12週、13-24週、25-36週。在第 13 週至第 24 週之間進行的檢查包括血液檢查和超音波檢查，以檢測遺傳性疾病或神經管缺陷。此時也進行超音波檢查以檢查解剖結構和相關疾病。無創產前檢測所需的耗材需求量大。人們對胎兒檢測的認識不斷提高，加上技術進步、支持性政府法規和先進的醫療基礎設施正在推動市場成長。

非侵入性產前檢測用於檢測單體、三體、微缺失症候群等。由於三體檢測的準確性高、母親年齡的增加以及人們對早期和非侵入性胎兒診斷的認識不斷提高，三體在全球無創產前檢測市場中佔有重要佔有率。三體性檢測測試從第 10 週開始進行，以提高檢測三種常見三體性（包括 21、18 和 13 號染色體）的安全性、可靠性和準確性。

各種非侵入性產前檢測方法包括母體血漿中的遊離 DNA 檢測、超音波檢測和生化篩檢檢測。預計母體血漿中的無細胞 DNA 片段在預測期內將顯著增長。透過這種方法提高染色體異常檢測的準確性、提高患者意識以及有效規劃妊娠管理是推動該細分市場成長的因素。

診斷中心、醫院、診所等提供非侵入性產前檢測服務。 2020年診斷中心產業佔比最高。染色體異常發生率的增加和政府的支持措施正在支持該細分市場的成長。專業設備、先進的醫療基礎設施和專家的存在進一步鼓勵患者前往診斷中心就診。

北美在 2020 年主導全球 NIPT 市場，預計在預測期內將保持其主導地位。高生活水平、對醫療保健服務的大量投資以及染色體異常發生率的增加正在支持該地區的市場成長。然而，亞太地區預計在預測期內將出現顯著成長。人口增長和胎兒檢測意識的提高正在推動該地區的成長。世界領先的公司正在中國、日本、印度和韓國等發展中國家擴大業務，以利用這些國家提供的成長機會。

由於技術的進步和滿足客戶需求的日益增長，各公司正在共同努力加強其在市場上的影響力並獲得市場佔有率。擴大產品組合是該行業的另一個趨勢。

主要市場參與者包括 Agilent Technologies, Inc.、Laboratory Corporation of America Holdings、Illumina, Inc.、F. Hoffman-La Roche Ltd.、Yourgene Health、Perkinelmer, Inc.、GE Healthcare、Quest Diagnostics、Thermo Fisher Scientific, Inc.、Sequenom、Qiagen NV、Koninklijke Philips NV、Natera, Inc.、北京華大基因研究所和Pacific Biosciences of California, Inc.

第一章目錄

第2章 簡介

第3章 執行概要

第4章 調查手法

第5章 非侵入性產前檢查市場洞察

  • 非侵入性產前檢查-產業概要
  • 非侵入性產前檢查市場動態
    • 促進因素和機會
    • 阻礙因素與課題
  • 大環境分析
  • 非侵入性產前檢查市場產業趨勢

第6章 各妊娠期間的非侵入性產前檢查市場評估

  • 主要調查結果
  • 簡介
    • 全球非侵入性產前檢查市場，各妊娠期間，2016～2028年
  • 0～12週
    • 全球非侵入性產前檢查市場，0～12週各，各地區，2016～2028年
  • 13～24週
    • 全球非侵入性產前檢查市場，13～24週各，各地區，2016～2028年
  • 25～36週
    • 全球非侵入性產前檢查市場，25～36週各，各地區，2016～2028年

第7章 全球非侵入性產前檢查市場:各組成類別

  • 主要調查結果
  • 簡介
  • 消耗品
  • 設備
  • 軟體
  • 服務

第八章全球非侵入性產前檢測市場：依應用劃分

  • 主要調查結果
  • 簡介
  • 單體性
  • 三體性
  • 微缺失症候群
  • 其他

第9章 各方法的非侵入性產前檢查市場評估

  • 主要調查結果
  • 簡介
    • 全球非侵入性產前檢查市場，各方法，2016～2028年
  • 母體血漿檢驗的脫離DNA
    • 全球非侵入性產前檢查市場，母體血漿檢驗的細胞脫離DNA，各地區，2016～2028年
  • 超音波檢測
    • 全球非侵入性產前檢查市場，超音波檢測，各地區，2016～2028年
  • 生物化學篩檢檢驗
    • 全球非侵入性產前檢查市場，生物化學篩檢檢查別，各地區，2016～2028年
  • 其他
    • 全球非侵入性產前檢查市場，其他，各地區，2016～2028年

第10章 全球非侵入性產前檢查市場:各最終用途

  • 主要調查結果
  • 簡介
  • 診斷中心
  • 醫院
  • 診所
  • 其他

第11章 各地區的非侵入性產前檢查市場評估

  • 主要調查結果
  • 簡介
    • 非侵入性產前檢查市場評估:地區，2016～2028年
  • 北美
    • 北美:各妊娠期間，2016～2028年
    • 北美:各組成類別，2016～2028年
    • 北美:各用途，2016～2028年
    • 北美:各方法，2016～2028年
    • 北美:各最終用途，2016～2028年
    • 美國
      • 美國:各妊娠期間，2016～2028年
      • 美國:各組成類別，2016～2028年
      • 美國:各用途，2016～2028年
      • 美國:各方法，2016～2028年
      • 美國:各最終用途，2016～2028年
    • 加拿大
      • 加拿大:各妊娠期間，2016～2028年
      • 加拿大:各組成類別，2016～2028年
      • 加拿大:申請，2016～2028年
      • 加拿大:各方法，2016～2028年
      • 加拿大:各最終用途，2016～2028年
  • 歐洲
    • 歐洲:各妊娠期間，2016～2028年
    • 歐洲:各組成類別，2016～2028年
    • 歐洲:各用途，2016～2028年
    • 歐洲:各方法，2016～2028年
    • 歐洲:各最終用途，2016～2028年
    • 英國
      • 英國:各妊娠期間，2016～2028年
      • 英國:各組成類別，2016～2028年
      • 英國:各用途，2016～2028年
      • 英國:各方法，2016～2028年
      • 英國:各最終用途，2016～2028年
    • 法國
      • 法國:各妊娠期間，2016～2028年
      • 法國:各組成類別，2016～2028年
      • 法國:各用途，2016～2028年
      • 法國:各方法，2016～2028年
      • 法國:各最終用途，2016～2028年
    • 德國
      • 德國:各妊娠期間，2016～2028年
      • 德國:各組成類別，2016～2028年
      • 德國:各用途，2016～2028年
      • 德國:各方法，2016～2028年
      • 德國:各最終用途，2016～2028年
    • 義大利
      • 義大利:各妊娠期間，2016～2028年
      • 義大利:各組成類別，2016～2028年
      • 義大利:各用途，2016～2028年
      • 義大利:各方法，2016～2028年
      • 義大利:各最終用途，2016～2028年
    • 西班牙
      • 西班牙:各妊娠期間，2016～2028年
      • 西班牙:各組成類別，2016～2028年
      • 西班牙:各用途，2016～2028年
      • 西班牙:各方法，2016～2028年
      • 西班牙:各最終用途，2016～2028年
    • 其他的歐洲
      • 其他的歐洲:各妊娠期間，2016～2028年
      • 其他的歐洲:各組成類別，2016～2028年
      • 其他的歐洲:各用途，2016～2028年
      • 其他的歐洲:各方法，2016～2028年
      • 其他的歐洲:各最終用途，2016～2028年
  • 亞太地區
    • 亞太地區:各妊娠期間，2016～2028年
    • 亞太地區:各組成類別，2016～2028年
    • 亞太地區:各用途，2016～2028年
    • 亞太地區:各方法，2016～2028年
    • 亞太地區:各最終用途，2016～2028年
    • 中國
      • 中國:各妊娠期間，2016～2028年
      • 中國:各組成類別，2016～2028年
      • 中國:各用途，2016～2028年
      • 中國:各方法，2016～2028年
      • 中國:各最終用途，2016～2028年
    • 印度
      • 印度:各妊娠期間，2016～2028年
      • 印度:各組成類別，2016～2028年
      • 印度:各用途，2016～2028年
      • 印度:各方法，2016～2028年
      • 印度:各最終用途，2016～2028年
    • 韓國
      • 韓國:各妊娠期間，2016～2028年
      • 韓國:各組成類別，2016～2028年
      • 韓國:各用途，2016～2028年
      • 韓國:各方法，2016～2028年
      • 韓國:各最終用途，2016～2028年
    • 日本
      • 日本:各妊娠期間，2016～2028年
      • 日本:各組成類別，2016～2028年
      • 日本:各用途，2016～2028年
      • 日本:各方法，2016～2028年
      • 日本:各最終用途，2016～2028年
    • 亞太地區
      • Ro亞太地區:各妊娠期間，2016～2028年
      • Ro亞太地區:各組成類別，2016～2028年
      • Ro亞太地區:各用途，2016～2028年
      • Ro亞太地區:各方法，2016～2028年
      • Ro亞太地區:各最終用途，2016～2028年
  • 中東·非洲
    • 中東·非洲:各妊娠期間，2016～2028年
    • 中東·非洲:各組成類別，2016～2028年
    • 中東·非洲:各用途，2016～2028年
    • 中東·非洲:各方法，2016～2028年
    • 中東·非洲:各最終用途，2016～2028年
    • 沙烏地阿拉伯
      • 沙烏地阿拉伯:各妊娠期間，2016～2028年
      • 沙烏地阿拉伯:各組成類別，2016～2028年
      • 沙烏地阿拉伯:各用途，2016～2028年
      • 沙烏地阿拉伯:各方法，2016～2028年
      • 沙烏地阿拉伯:各最終用途，2016～2028年
    • 阿拉伯聯合大公國
      • 阿拉伯聯合大公國:各妊娠期間，2016～2028年
      • 阿拉伯聯合大公國:各組成類別，2016～2028年
      • 阿拉伯聯合大公國:各用途，2016～2028年
      • 阿拉伯聯合大公國:各方法，2016～2028年
      • 阿拉伯聯合大公國:各最終用途，2016～2028年
    • 以色列
      • 以色列:各妊娠期間，2016～2028年
      • 以色列:各組成類別，2016～2028年
      • 以色列:各用途，2016～2028年
      • 以色列:各方法，2016～2028年
      • 以色列:各最終用途，2016～2028年
    • 南非
      • 南非:各妊娠期間，2016～2028年
      • 南非:各組成類別，2016～2028年
      • 南非:各用途，2016～2028年
      • 南非:各方法，2016～2028年
      • 南非:各最終用途，2016～2028年
    • 其他的中東·非洲
      • 其他的中東·非洲:各妊娠期間，2016～2028年
      • 其他的中東·非洲:各組成類別，2016～2028年
      • 其他的中東·非洲:各用途，2016～2028年
      • 其他的中東·非洲:各方法，2016～2028年
      • 其他的中東·非洲:各最終用途，2016～2028年
  • 南美
    • 南美:各妊娠期間，2016～2028年
    • 南美:各組成類別，2016～2028年
    • 南美:各用途，2016～2028年
    • 南美:各方法，2016～2028年
    • 南美:各最終用途，2016～2028年
    • 墨西哥
      • 墨西哥:各妊娠期間，2016～2028年
      • 墨西哥:各組成類別，2016～2028年
      • 墨西哥:各用途，2016～2028年
      • 墨西哥:各方法，2016～2028年
      • 墨西哥:各最終用途，2016～2028年
    • 巴西
      • 巴西:各妊娠期間，2016～2028年
      • 巴西:各組成類別，2016～2028年
      • 巴西:各用途，2016～2028年
      • 巴西:各方法，2016～2028年
      • 巴西:各最終用途，2016～2028年
    • 哥倫比亞
      • 哥倫比亞:各妊娠期間，2016～2028年
      • 哥倫比亞:各組成類別，2016～2028年
      • 哥倫比亞:各用途，2016～2028年
      • 哥倫比亞:各方法，2016～2028年
      • 哥倫比亞:各最終用途，2016～2028年
    • 其他的南美
      • 其他的南美:各妊娠期間，2016～2028年
      • 其他的南美:各組成類別，2016～2028年
      • 其他的南美:各用途，2016～2028年
      • 其他的南美:各方法，2016～2028年
      • 其他的南美:各最終用途，2016～2028年

第12章 競爭情形

  • 擴大和收購的分析
    • 擴大
  • 聯盟/合作/協定/公開

第13章 企業簡介

  • Agilent Technologies, Inc.
  • Laboratory Corporation of America Holdings
  • Illumina, Inc.
  • F. Hoffman-La Roche Ltd.
  • Yourgene Health
  • Perkinelmer, Inc.
  • GE Healthcare
  • Quest Diagnostics
  • Thermo Fisher Scientific, Inc.
  • Sequenom
Product Code: PM1836

The global non-invasive prenatal testing (NIPT) market size is expected to reach USD 10.10 billion by 2032 according to a new study by Polaris Market Research. The report "Non-Invasive Prenatal Testing (NIPT) Market Share, Size, Trends, Industry Analysis Report, By Gestation Period (0-12 weeks, 13-24 weeks, 25-36 weeks); By Component (Consumables, Instruments, Software, Services); By Method; By Application; By End-Use; By Regions; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market demand for non-invasive prenatal testing is expected to increase during the forecast period owing to growth in the occurrence of genetic disorders, increasing awareness regarding early fetal testing, and advancing maternal age. The significant market growth in healthcare infrastructure, technological advancements, and favorable regulations are some factors expected to provide growth opportunities during the forecast period.

The gestation period segment has been divided into 0-12 weeks, 13-24 weeks, 25-36 weeks. Testing performed for 13 - 24 weeks involves blood tests and ultrasound to detect genetic disorders and neural tube defects. Ultrasounds are also used in this period to examine the anatomy and associated disorders. There has been a high demand for consumables required during non-invasive prenatal testing. The rising awareness regarding fetal testing, coupled with technological advancements, supportive government regulations, and advanced healthcare infrastructure boosts the market growth.

Non-invasive prenatal testing is used for the detection of Monosomy, Trisomy, Microdeletion Syndrome, and Others. The trisomy accounted for a major share of the global market for non-invasive prenatal testing owing to high accuracy in detection of trisomy, growing maternal age, and increasing awareness regarding early and non-invasive fetal diagnosis. The test for detection of trisomy is performed after 10 weeks for enhanced safety, reliability, and accuracy for detection of the three common trisomy including chromosomes 21, 18, and 13.

The different methods of non-invasive prenatal testing include cell-free DNA in maternal plasma tests, ultrasound detection, biochemical screening tests, and others. The cell-free DNA in the maternal plasma segment is expected to grow significantly during the forecast period. The increasing accuracy in the detection of chromosomal abnormalities through this method, growing patient awareness, and efficient planning for pregnancy management are some factors driving the growth of this segment.

Non-invasive prenatal testing services are offered in diagnostic centers, hospitals, clinics, and others. The diagnostic centers segment accounted for the highest share in 2020. The increasing occurrence of chromosomal abnormalities coupled with supportive government initiatives supports the growth of this segment. The presence of specialized equipment, advanced healthcare infrastructure, and expert professionals further encourage patients to visit diagnostic centers.

North America dominated the global NIPT market in 2020 and is expected to maintain its dominance over the forecast period. High living standards, significant investment in healthcare services, and increasing occurrence of chromosome abnormalities support market growth in this region. However, Asia-Pacific is expected to exhibit significant growth during the forecast period. Increasing population coupled with increasing awareness regarding fetal testing fuels growth in this region. Leading global players are expanding their presence in developing nations of China, Japan, India, and South Korea to tap the growth opportunities offered by these countries.

On account of the technological advancements, and greater need to cater to customer requirements, companies are collaborating in order to strengthen the market presence and gain market share. Broadening of the product portfolio is another trend that is visible in the industry.

Some of the major market participants include Agilent Technologies, Inc., Laboratory Corporation of America Holdings, Illumina, Inc., F. Hoffman-La Roche Ltd., Yourgene Health, Perkinelmer, Inc., GE Healthcare, Quest Diagnostics, Thermo Fisher Scientific, Inc., Sequenom, Qiagen N.V., Koninklijke Philips N.V., Natera, Inc., Beijing Genomics Institute, and Pacific Biosciences of California, Inc.

Polaris Market Research has segmented the non-invasive prenatal testing (NIPT) market report on the basis of gestation period, component, method, application, end-use, and region:

Non-Invasive Prenatal Testing (NIPT) Gestation Period Outlook (Revenue, USD Million, 2016 - 2028)

  • 0-12 weeks
  • 13-24 weeks
  • 25-36 weeks

Non-Invasive Prenatal Testing (NIPT) Component Outlook (Revenue, USD Million, 2016 - 2028)

  • Consumables
  • Instruments
  • Software
  • Services

Non-Invasive Prenatal Testing (NIPT) Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Monosomy
  • Trisomy
  • Microdeletion Syndrome
  • Others

Non-Invasive Prenatal Testing (NIPT) Method Outlook (Revenue, USD Million, 2016 - 2028)

  • Cell-Free DNA in Maternal Plasma Tests
  • Ultrasound Detection
  • Biochemical Screening Tests
  • Others

Non-Invasive Prenatal Testing (NIPT) End-Use Outlook (Revenue, USD Million, 2016 - 2028)

  • Diagnostic Centers
  • Hospitals
  • Clinics
  • Others

Non-Invasive Prenatal Testing (NIPT) Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • RoE
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Colombia
  • RoLATAM
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Israel
  • UAE
  • RoMEA

1. Table of Contents

2. Introduction

  • 2.1. Report Description
    • 2.1.1. Objectives of the Study
    • 2.1.2. Market Scope
    • 2.1.3. Assumptions
  • 2.2. Stakeholders

3. Executive Summary

  • 3.1. Market Highlights

4. Research Methodology

  • 4.1. Overview
    • 4.1.1. Data Mining
  • 4.2. Data Sources
    • 4.2.1. Primary Sources
    • 4.2.2. Secondary Sources

5. Non-Invasive Prenatal Testing (NIPT) Market Insights

  • 5.1. Non-Invasive Prenatal Testing (NIPT) - Industry snapshot
  • 5.2. Non-Invasive Prenatal Testing (NIPT) Market Dynamics
    • 5.2.1. Drivers and Opportunities
    • 5.2.2. Restraints and Challenges
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining Power of Suppliers (Moderate)
    • 5.3.2. Threats of New Entrants: (Low)
    • 5.3.3. Bargaining Power of Buyers (Moderate)
    • 5.3.4. Threat of Substitute (Moderate)
    • 5.3.5. Rivalry among existing firms (High)
  • 5.4. PESTLE Analysis
  • 5.5. Non-Invasive Prenatal Testing (NIPT) Market Industry trends

6. Non-Invasive Prenatal Testing (NIPT) Market Assessment by Gestation Period

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • 6.3. 0-12 weeks
    • 6.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 0-12 weeks, by Region, 2016 - 2028 (USD Million
  • 6.4. 13-24 weeks
    • 6.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 13-24 weeks, by Region, 2016 - 2028 (USD Million)
  • 6.5. 25-36 weeks
    • 6.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 25-36 weeks, by Region, 2016 - 2028 (USD Million)

7. Global Non-Invasive Prenatal Testing (NIPT) Market, by Component

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • 7.3. Consumables
    • 7.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Consumables, By Region, 2016 - 2028 (USD Million)
  • 7.4. Instruments
    • 7.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Instruments, by Region, 2016 - 2028 (USD Million)
  • 7.5. Software
    • 7.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Software, by Region, 2016 - 2028 (USD Million)
  • 7.6. Services
    • 7.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Services, by Region, 2016 - 2028 (USD Million)

8. Global Non-Invasive Prenatal Testing (NIPT) Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • 8.3. Monosomy
    • 8.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Monosomy, By Region, 2016 - 2028 (USD Million)
  • 8.4. Trisomy
    • 8.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Trisomy, by Region, 2016 - 2028 (USD Million)
  • 8.5. Microdeletion Syndrome
    • 8.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Microdeletion Syndrome, by Region, 2016 - 2028 (USD Million)
  • 8.6. Others
    • 8.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Other Applications, by Region, 2016 - 2028 (USD Million)

9. Non-Invasive Prenatal Testing (NIPT) Market Assessment by Method

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • 9.3. Cell-Free DNA in Maternal Plasma Tests
    • 9.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Cell-Free DNA in Maternal Plasma Tests, by Region, 2016 - 2028 (USD Million)
  • 9.4. Ultrasound Detection
    • 9.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Ultrasound Detection, by Region, 2016 - 2028 (USD Million)
  • 9.5. Biochemical Screening Tests
    • 9.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Biochemical Screening Tests, by Region, 2016 - 2028 (USD Million)
  • 9.6. Others
    • 9.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Others, by Region, 2016 - 2028 (USD Million)

10. Global Non-Invasive Prenatal Testing (NIPT) Market, by End-Use

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • 10.3. Diagnostic Centers
    • 10.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Diagnostic Centers, By Region, 2016 - 2028 (USD Million)
  • 10.4. Hospitals
    • 10.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Hospitals, by Region, 2016 - 2028 (USD Million)
  • 10.5. Clinics
    • 10.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Clinics, by Region, 2016 - 2028 (USD Million)
  • 10.6. Others
    • 10.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Other End-Uses, by Region, 2016 - 2028 (USD Million)

11. Non-Invasive Prenatal Testing (NIPT) Market Assessment by Geography

  • 11.1. Key findings
  • 11.2. Introduction
    • 11.2.1. Non-Invasive Prenatal Testing (NIPT) Market Assessment, By Geography, 2016 - 2028 (USD Million)
  • 11.3. Non-Invasive Prenatal Testing (NIPT) Market - North America
    • 11.3.1. North America: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
    • 11.3.2. North America: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
    • 11.3.3. North America: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
    • 11.3.4. North America: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
    • 11.3.5. North America: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.3.6. Non-Invasive Prenatal Testing (NIPT) Market - U.S.
      • 11.3.6.1. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.3.6.2. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.3.6.3. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.3.6.4. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.3.6.5. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.3.7. Non-Invasive Prenatal Testing (NIPT) Market - Canada
      • 11.3.7.1. Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.3.7.2. Canada.: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.3.7.3. Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.3.7.4. Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.3.7.5. Canada: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • 11.4. Non-Invasive Prenatal Testing (NIPT) Market - Europe
    • 11.4.1. Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
    • 11.4.2. Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
    • 11.4.3. Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
    • 11.4.4. Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
    • 11.4.5. Europe: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.6. Non-Invasive Prenatal Testing (NIPT) Market - UK
      • 11.4.6.1. UK: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.6.2. UK: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.6.3. UK: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.6.4. UK: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.6.5. UK: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.7. Non-Invasive Prenatal Testing (NIPT) Market - France
      • 11.4.7.1. France: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.7.2. France: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.7.3. France: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.7.4. France: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.7.5. France: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.8. Non-Invasive Prenatal Testing (NIPT) Market - Germany
      • 11.4.8.1. Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.8.2. Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.8.3. Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.8.4. Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.8.5. Germany: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.9. Non-Invasive Prenatal Testing (NIPT) Market - Italy
      • 11.4.9.1. Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.9.2. Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.9.3. Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.9.4. Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.9.5. Italy: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.10. Non-Invasive Prenatal Testing (NIPT) Market - Spain
      • 11.4.10.1. Spain: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.10.2. Spain: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.10.3. Spain: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.10.4. Spain: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.10.5. Spain: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.11. Non-Invasive Prenatal Testing (NIPT) Market - RoE
      • 11.4.11.1. RoE: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.11.2. RoE: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.11.3. RoE: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.11.4. RoE: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.11.5. RoE: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • 11.5. Non-Invasive Prenatal Testing (NIPT) Market - Asia-Pacific
    • 11.5.1. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
    • 11.5.2. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
    • 11.5.3. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
    • 11.5.4. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
    • 11.5.5. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.5.6. Non-Invasive Prenatal Testing (NIPT) Market - China
      • 11.5.6.1. China: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.5.6.2. China: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.5.6.3. China: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.5.6.4. China: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.5.6.5. China: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.5.7. Non-Invasive Prenatal Testing (NIPT) Market - India
      • 11.5.7.1. India: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.5.7.2. India: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.5.7.3. India: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.5.7.4. India: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.5.7.5. India: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.5.8. Non-Invasive Prenatal Testing (NIPT) Market - South Korea
      • 11.5.8.1. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.5.8.2. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.5.8.3. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.5.8.4. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.5.8.5. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.5.9. Non-Invasive Prenatal Testing (NIPT) Market - Japan
      • 11.5.9.1. Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.5.9.2. Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.5.9.3. Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.5.9.4. Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.5.9.5. Japan: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.5.10. Non-Invasive Prenatal Testing (NIPT) Market - RoAPAC
      • 11.5.10.1. RoAPAC: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.5.10.2. RoAPAC: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.5.10.3. RoAPAC: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.5.10.4. RoAPAC: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.5.10.5. RoAPAC: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • 11.6. Non-Invasive Prenatal Testing (NIPT) Market - Middle East & Africa
    • 11.6.1. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
    • 11.6.2. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
    • 11.6.3. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
    • 11.6.4. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
    • 11.6.5. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.6.6. Non-Invasive Prenatal Testing (NIPT) Market - Saudi Arabia
      • 11.6.6.1. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.6.6.2. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.6.6.3. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.6.6.4. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.6.6.5. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.6.7. Non-Invasive Prenatal Testing (NIPT) Market - UAE
      • 11.6.7.1. UAE: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.6.7.2. UAE: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.6.7.3. UAE: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.6.7.4. UAE: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.6.7.5. UAE: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.6.8. Non-Invasive Prenatal Testing (NIPT) Market - Israel
      • 11.6.8.1. Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.6.8.2. Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.6.8.3. Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.6.8.4. Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.6.8.5. Israel: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.6.9. Non-Invasive Prenatal Testing (NIPT) Market - South Africa
      • 11.6.9.1. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.6.9.2. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.6.9.3. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.6.9.4. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.6.9.5. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.6.10. Non-Invasive Prenatal Testing (NIPT) Market - RoMEA
      • 11.6.10.1. RoMEA: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.6.10.2. RoMEA: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.6.10.3. RoMEA: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.6.10.4. RoMEA: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.6.10.5. RoMEA: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • 11.7. Non-Invasive Prenatal Testing (NIPT) Market - Latin America
    • 11.7.1. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
    • 11.7.2. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
    • 11.7.3. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
    • 11.7.4. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
    • 11.7.5. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.7.6. Non-Invasive Prenatal Testing (NIPT) Market - Mexico
      • 11.7.6.1. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.7.6.2. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.7.6.3. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.7.6.4. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.7.6.5. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.7.7. Non-Invasive Prenatal Testing (NIPT) Market - Brazil
      • 11.7.7.1. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.7.7.2. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.7.7.3. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.7.7.4. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.7.7.5. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.7.8. Non-Invasive Prenatal Testing (NIPT) Market - Colombia
      • 11.7.8.1. Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.7.8.2. Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.7.8.3. Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.7.8.4. Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.7.8.5. Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.7.9. Non-Invasive Prenatal Testing (NIPT) Market - RoLATAM
      • 11.7.9.1. RoLATAM: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.7.9.2. RoLATAM: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.7.9.3. RoLATAM: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.7.9.4. RoLATAM: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.7.9.5. RoLATAM: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)

12. Competitive Landscape

  • 12.1. Expansion and Acquisition Analysis
    • 12.1.1. Expansion
  • 12.2. Partnerships/Collaborations/Agreements/Exhibitions

13. Company Profiles

  • 13.1. Agilent Technologies, Inc.
    • 13.1.1. Company Overview
    • 13.1.2. Financial PerMethodance
    • 13.1.3. Product Benchmarking
    • 13.1.4. Recent Development
  • 13.2. Laboratory Corporation of America Holdings
    • 13.2.1. Company Overview
    • 13.2.2. Financial PerMethodance
    • 13.2.3. Product Benchmarking
    • 13.2.4. Recent Development
  • 13.3. Illumina, Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Financial PerMethodance
    • 13.3.3. Product Benchmarking
    • 13.3.4. Recent Development
  • 13.4. F. Hoffman-La Roche Ltd.
    • 13.4.1. Company Overview
    • 13.4.2. Financial PerMethodance
    • 13.4.3. Product Benchmarking
    • 13.4.4. Recent Development
  • 13.5. Yourgene Health
    • 13.5.1. Company Overview
    • 13.5.2. Financial PerMethodance
    • 13.5.3. Product Benchmarking
    • 13.5.4. Recent Development
  • 13.6. Perkinelmer, Inc.
    • 13.6.1. Company Overview
    • 13.6.2. Financial PerMethodance
    • 13.6.3. Product Benchmarking
    • 13.6.4. Recent Development
  • 13.7. GE Healthcare
    • 13.7.1. Company Overview
    • 13.7.2. Financial PerMethodance
    • 13.7.3. Product Benchmarking
    • 13.7.4. Recent Development
  • 13.8. Quest Diagnostics
    • 13.8.1. Company Overview
    • 13.8.2. Financial PerMethodance
    • 13.8.3. Product Benchmarking
    • 13.8.4. Recent Development
  • 13.9. Thermo Fisher Scientific, Inc.
    • 13.9.1. Company Overview
    • 13.9.2. Financial PerMethodance
    • 13.9.3. Product Benchmarking
    • 13.9.4. Recent Development
  • 13.10. Sequenom
    • 13.10.1. Company Overview
    • 13.10.2. Financial PerMethodance
    • 13.10.3. Product Benchmarking
    • 13.10.4. Recent Development

List of Tables

  • Table 1 Global Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 2 Global Non-Invasive Prenatal Testing (NIPT) Market, by Component, by Region, 2016 - 2028 (USD Million)
  • Table 3 Global Non-Invasive Prenatal Testing (NIPT) Market, by Application, by Region, 2016 - 2028 (USD Million)
  • Table 4 Global Non-Invasive Prenatal Testing (NIPT) Market, by Method, by Region, 2016 - 2028 (USD Million)
  • Table 5 Global Non-Invasive Prenatal Testing (NIPT) Market, by End-Use, by Region, 2016 - 2028 (USD Million)
  • Table 6 Non-Invasive Prenatal Testing (NIPT) Market Assessment, By Geography, 2016 - 2028 (USD Million)
  • Table 7 North America: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 8 North America: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 9 North America: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 10 North America: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 11 North America: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 12 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 13 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 14 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 15 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 16 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 17 Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 18 Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 19 Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 20 Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 21 Canada: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 22 Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 23 Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 24 Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 25 Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 26 Europe: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 27 UK: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 28 UK: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 29 UK: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 30 UK: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 31 UK: Non-Invasive Prenatal Testing (NIPT) Market, By End-Uses, 2016 - 2028 (USD Million)
  • Table 32 France: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 33 France: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 34 France: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 35 France: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 36 France: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 37 Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 38 Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 39 Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 40 Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 41 Germany: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 42 Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 43 Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 44 Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 45 Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 46 Italy: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 47 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 48 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 49 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 50 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 51 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 52 Austria: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 53 Austria: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 54 Austria: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 55 Austria: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 56 Austria: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 57 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 58 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 59 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 60 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 61 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 62 China: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 63 China: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 64 China: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 65 China: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 66 China: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 67 India: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 68 India: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 69 India: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 70 India: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 71 India: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 72 Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 73 Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 74 Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 75 Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 76 Japan: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 77 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 78 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 79 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 80 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 81 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 82 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 83 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 84 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 85 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 86 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 87 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 88 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 89 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 90 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 91 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By End-Uses, 2016 - 2028 (USD Million)
  • Table 92 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 93 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 94 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 95 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 96 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 97 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 98 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 99 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 100 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 101 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 102 Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 103 Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 104 Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 105 Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 106 Israel: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 107 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 108 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 109 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 110 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 111 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 112 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 113 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 114 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 115 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 116 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 117 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 118 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 119 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 120 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 121 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 122 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 123 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 124 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 125 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 126 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 127 Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 128 Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 129 Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 130 Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 131 Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)

List of Figures

  • Figure 1. Market Highlights (2020, Revenue)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Component
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Gestation Period
  • Figure 7. Global Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2020 & 2028 (USD Million)
  • Figure 8. Market by Component
  • Figure 9. Global Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2020 & 2028 (USD Million)
  • Figure 10. Global Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2020 & 2028 (USD Million)
  • Figure 11. Market by Method
  • Figure 12. Global Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2020 & 2028 (USD Million)
  • Figure 13. Non-Invasive Prenatal Testing (NIPT) Market Assessment, By Geography, 2016 - 2028 (USD Million)
  • Figure 14. Strategic Analysis - Non-Invasive Prenatal Testing (NIPT) Market